| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |